Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 23, Issue 8

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 23, Issue 8 (2014)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 23, Issue 8 (2014)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Volume 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Biomarkers and personalized therapy in chronic kidney diseases

Francesco Paolo Schena

Pages: 1051-1054

Published online: 26 May 2014

AbstractforBiomarkers and personalized therapy in chronic kidney diseases | Full Text | References | PDF (146.7 KB)

1475 Views
6 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies

V Margaret Jackson, David A Price & Philip A Carpino

Pages: 1055-1066

Published online: 07 Jul 2014

AbstractforInvestigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies | Full Text | References | PDF (327.4 KB)

879 Views
19 CrossRef citations
0Altmetric

Review Article

Selective JAK inhibitors in development for rheumatoid arthritis

Peter Norman MBA PhD

Pages: 1067-1077

Published online: 12 May 2014

AbstractforSelective JAK inhibitors in development for rheumatoid arthritis | Full Text | References | PDF (417.6 KB)

4548 Views
114 CrossRef citations
0Altmetric

Review Article

Current status of drugs in development for celiac disease

Kalle Kurppa, Minna Hietikko, Ana-Marija Sulic, Katri Kaukinen & Katri Lindfors

Pages: 1079-1091

Published online: 07 May 2014

AbstractforCurrent status of drugs in development for celiac disease | Full Text | References | PDF (694.5 KB)

387 Views
10 CrossRef citations
0Altmetric

Review Article

New investigational drugs for the treatment of neuropathic pain

Kinga Sałat, Paula Kowalczyk, Beata Gryzło, Anna Jakubowska & Katarzyna Kulig

Pages: 1093-1104

Published online: 04 Jun 2014

AbstractforNew investigational drugs for the treatment of neuropathic pain | Full Text | References | PDF (538 KB)

1212 Views
33 CrossRef citations
0Altmetric

Review Article

Drugs currently in Phase II clinical trials for cocaine addiction

Jee Hyun Kim PhD & Andrew J Lawrence PhD FBPharmacolS

Pages: 1105-1122

Published online: 29 Apr 2014

AbstractforDrugs currently in Phase II clinical trials for cocaine addiction | Full Text | References | PDF (473.6 KB)

692 Views
31 CrossRef citations
0Altmetric

Review Article

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands

Mellar P Davis MD FCCP FAAHPM

Pages: 1123-1140

Published online: 16 May 2014

AbstractforCannabinoids in pain management: CB1, CB2 and non-classic receptor ligands | Full Text | References | PDF (567.4 KB)

1654 Views
59 CrossRef citations
0Altmetric

Review Article

Drugs targeting nitric oxide synthase for migraine treatment

Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Luisa Fofi & David Della-Morte

Pages: 1141-1148

Published online: 12 May 2014

AbstractforDrugs targeting nitric oxide synthase for migraine treatment | Full Text | References | PDF (224 KB)

469 Views
28 CrossRef citations
0Altmetric

Drug Evaluations

Bedoradrine for treating asthma and chronic obstructive pulmonary disease

Sabina Antoniu MD PhD

Pages: 1149-1156

Published online: 18 Jun 2014

AbstractforBedoradrine for treating asthma and chronic obstructive pulmonary disease | Full Text | References | PDF (226.1 KB)

185 Views
4 CrossRef citations
0Altmetric

Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder

Carl Fleisher MD & James McGough MD

Pages: 1157-1163

Published online: 26 Jun 2014

AbstractforSofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder | Full Text | References | PDF (271.4 KB)

323 Views
7 CrossRef citations
0Altmetric

Mavoglurant as a treatment for Parkinson’s disease

Dmitry Petrov, Ignacio Pedros, Maria Luisa de Lemos, Mercè Pallàs, Anna Maria Canudas, Alberto Lazarowski, Carlos Beas-Zarate, Carme Auladell, Jaume Folch & Antoni Camins

Pages: 1165-1179

Published online: 24 Jun 2014

AbstractforMavoglurant as a treatment for Parkinson’s disease | Full Text | References | PDF (391.7 KB)

449 Views
27 CrossRef citations
0Altmetric

Article

Page: i

Published online: 11 Jul 2014

65 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Investigational drugs for the treatment of acromegaly: new agents to transform therapy

Rosa Pirchio et al.

Review Article | Published online: 30 Apr 2024

Safety, tolerability, and pharmacokinetics of the novel RdRp inhibitor SHEN26 against SARS-CoV-2: a randomized, placebo-controlled, double-blind Phase I study in healthy subjects

Cheng Sun et al.

Article | Published online: 30 Apr 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 30 Apr 2024

Open Access

Drugs in preclinical and early clinical development for the treatment of chagas disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 30 Apr 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.23, Iss.8, 2014)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?